JP2023175708A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023175708A5 JP2023175708A5 JP2023136194A JP2023136194A JP2023175708A5 JP 2023175708 A5 JP2023175708 A5 JP 2023175708A5 JP 2023136194 A JP2023136194 A JP 2023136194A JP 2023136194 A JP2023136194 A JP 2023136194A JP 2023175708 A5 JP2023175708 A5 JP 2023175708A5
- Authority
- JP
- Japan
- Prior art keywords
- autoantigen
- alpha
- synuclein
- kit according
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15192794 | 2015-11-03 | ||
| EP15192794.4 | 2015-11-03 | ||
| JP2018541534A JP7378931B2 (ja) | 2015-11-03 | 2016-11-02 | ヒト患者における自己抗原に対するワクチン接種法 |
| PCT/EP2016/076372 WO2017076873A1 (en) | 2015-11-03 | 2016-11-02 | Method for vaccination against a self-antigen in a human patient |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541534A Division JP7378931B2 (ja) | 2015-11-03 | 2016-11-02 | ヒト患者における自己抗原に対するワクチン接種法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023175708A JP2023175708A (ja) | 2023-12-12 |
| JP2023175708A5 true JP2023175708A5 (https=) | 2024-04-01 |
| JP7628333B2 JP7628333B2 (ja) | 2025-02-10 |
Family
ID=54396782
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541534A Active JP7378931B2 (ja) | 2015-11-03 | 2016-11-02 | ヒト患者における自己抗原に対するワクチン接種法 |
| JP2023136194A Active JP7628333B2 (ja) | 2015-11-03 | 2023-08-24 | ヒト患者における自己抗原に対するワクチン接種法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541534A Active JP7378931B2 (ja) | 2015-11-03 | 2016-11-02 | ヒト患者における自己抗原に対するワクチン接種法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12290553B2 (https=) |
| EP (1) | EP3370761A1 (https=) |
| JP (2) | JP7378931B2 (https=) |
| KR (1) | KR102857456B1 (https=) |
| CN (1) | CN108472344A (https=) |
| AU (1) | AU2016348610B2 (https=) |
| BR (1) | BR112018008697A2 (https=) |
| CA (1) | CA3003943A1 (https=) |
| RU (1) | RU2734924C2 (https=) |
| WO (1) | WO2017076873A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3003943A1 (en) * | 2015-11-03 | 2017-05-11 | Affiris Ag | Method for vaccination against a self-antigen in a human patient |
| AR111760A1 (es) | 2017-05-19 | 2019-08-14 | Novartis Ag | Compuestos y composiciones para el tratamiento de tumores sólidos mediante administración intratumoral |
| CA3100857A1 (en) * | 2018-05-22 | 2019-11-28 | The Governors Of The University Of Alberta | Innocuous, structured scaffolds for structure-based amyloid disease vaccines and antigens |
| JP2023536497A (ja) | 2020-08-04 | 2023-08-25 | エイシー イミューン ソシエテ アノニム | 免疫原性化合物 |
| KR102527616B1 (ko) | 2021-03-18 | 2023-05-02 | 정성욱 | 항체 관련 정보를 제공하는 방법 및 디바이스 |
| US20250152684A1 (en) | 2022-02-09 | 2025-05-15 | Ac Immune Sa | Anti-Alpha-Synuclein Therapeutic Vaccines |
| WO2025172592A1 (en) | 2024-02-15 | 2025-08-21 | Ac Immune Sa | Alpha synuclein therapeutic vaccine |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101077416A (zh) * | 2002-10-23 | 2007-11-28 | 葛兰素史密丝克莱恩生物有限公司 | 抗疟疾的疫苗接种方法 |
| AT413945B (de) | 2003-01-14 | 2006-07-15 | Mattner Frank Dr | Impfstoff für die alzheimer-krankheit |
| AT413946B (de) | 2004-07-13 | 2006-07-15 | Mattner Frank Dr | Impfstoff gegen die alzheimer-krankheit |
| AT506535B1 (de) * | 2008-02-22 | 2010-04-15 | Affiris Forschungs & Entwicklungs Gmbh | Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden |
| AT508569A1 (de) * | 2009-07-23 | 2011-02-15 | Affiris Ag | Pharmaceutical compound |
| AT508638B1 (de) | 2009-08-21 | 2011-08-15 | Affiris Ag | Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien |
| PE20161551A1 (es) * | 2009-09-03 | 2017-01-18 | Pfizer Vaccines Llc | Vacuna de pcsk9 |
| SG10201501980SA (en) * | 2009-12-15 | 2015-05-28 | Novartis Ag | Homogeneous suspension of immunopotentiating compounds and uses thereof |
| EP2659907A1 (en) * | 2012-05-01 | 2013-11-06 | Affiris AG | Compositions |
| EP2666785A1 (en) | 2012-05-23 | 2013-11-27 | Affiris AG | Complement component C5a-based vaccine |
| EP2703483A1 (en) * | 2012-08-29 | 2014-03-05 | Affiris AG | PCSK9 peptide vaccine |
| JP6494667B2 (ja) | 2014-02-28 | 2019-04-03 | アフィリス・アクチェンゲゼルシャフトＡｆｆｉｒｉｓ Ａｇ | Ｐｃｓｋ９ワクチン |
| CA3003943A1 (en) * | 2015-11-03 | 2017-05-11 | Affiris Ag | Method for vaccination against a self-antigen in a human patient |
-
2016
- 2016-11-02 CA CA3003943A patent/CA3003943A1/en active Pending
- 2016-11-02 CN CN201680064233.5A patent/CN108472344A/zh active Pending
- 2016-11-02 KR KR1020187015512A patent/KR102857456B1/ko active Active
- 2016-11-02 AU AU2016348610A patent/AU2016348610B2/en active Active
- 2016-11-02 BR BR112018008697-5A patent/BR112018008697A2/en active Search and Examination
- 2016-11-02 US US15/772,572 patent/US12290553B2/en active Active
- 2016-11-02 JP JP2018541534A patent/JP7378931B2/ja active Active
- 2016-11-02 WO PCT/EP2016/076372 patent/WO2017076873A1/en not_active Ceased
- 2016-11-02 RU RU2018120009A patent/RU2734924C2/ru active
- 2016-11-02 EP EP16793798.6A patent/EP3370761A1/en active Pending
-
2023
- 2023-08-24 JP JP2023136194A patent/JP7628333B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023175708A5 (https=) | ||
| TWI232753B (en) | Adjuvant compositions comprising QS-21,3D-MPL and CpG and vaccine compositions comprising the same | |
| ES2179105T5 (es) | Adyuvantes proteinicos. | |
| JP2018532782A5 (https=) | ||
| Chen et al. | High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants | |
| Brennan et al. | Cowpea mosaic virus as a vaccine carrier of heterologous antigens | |
| ES2141750T5 (es) | Composicion que contiene a la vez una forma soluble y una forma insoluble de un inmunogeno. | |
| CN102256620B (zh) | 用于治疗阿尔茨海默氏病的免疫治疗组合物 | |
| Levi et al. | Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes | |
| De Haan et al. | Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice | |
| RU2007145052A (ru) | Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера | |
| JP2012506411A5 (https=) | ||
| JP2011042693A5 (https=) | ||
| JP2003513935A5 (https=) | ||
| RU2018120009A (ru) | Способ вакцинации против аутоантигена у пациента-человека | |
| WO2013164354A1 (en) | Composition | |
| JP2007513992A (ja) | 自己免疫疾患の治療用のｉｌ−１２又はｉｌ−２３を含むワクチン | |
| AU2016271857B2 (en) | IL-23-P19 vaccines | |
| RU2130778C1 (ru) | Комбинированная вакцина для иммунопрофилактики вирусного гепатита в, столбняка, дифтерии и коклюша | |
| US20080311152A1 (en) | Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer | |
| US8575319B2 (en) | Cleavable vaccine compositions and uses thereof and methods of making and using the same | |
| JP4889175B2 (ja) | 感染性因子に対する免疫応答を刺激するための組成物および方法 | |
| JP2016532712A (ja) | 薬物中毒に対するワクチン組成物 | |
| WO1998046263A1 (en) | Saponin adjuvants in combination with dna vaccination | |
| Allison | Antigens and adjuvants for a new generation of vaccines |